C12N 2501/2308
Interleukin-8
Official title: Interleukin-8 (IL-8)
C12N2501/2308 (Interleukin-8) appears on 17 US grants and 38 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 38
- Assignees
- 23
- Inventors
- 70
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 2 |
| 2018 | 1 | 4 |
| 2019 | 0 | 2 |
| 2020 | 0 | 5 |
| 2021 | 2 | 7 |
| 2022 | 2 | 2 |
| 2023 | 3 | 2 |
| 2024 | 6 | 6 |
| 2025 | 2 | 5 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Biocompatible conditioned cell medium compositions and uses thereof16 Jun 2026US 12,655,384 B2Cellum Biomedical, Inc.
- Lyophilized compositions containing umbilical cord lining stem cells conditioned medium4 Nov 2025US 12,460,179 B2Restem LLC
- Cancer-killing cells29 Jul 2025US 12,370,216 B2LIfT BioSciences Ltd
- Method of preparing in vitro-matured human intestinal organoids and use thereof31 Dec 2024US 12,180,508 B2Korea Research Institute of Bioscience and Biotechnology
- Precursory regulatory cytotrophoblast cells and uses thereof3 Sep 2024US 12,077,777 B2Accelerated Biosciences Corp.
- Cancer-killing cells23 Jul 2026US 2026/0207663 A2LIfT BioSciences Ltd
- Method of treating heart failure in subjects with persistent inflammation16 Jul 2026US 2026/0199396 A1Mesoblast International Sarl
- Pre-licensed composition and cell culture methods16 Jul 2026US 2026/0201337 A1Mesoblast International Sarl
- Recombinant production of growth factors in algae for cell culture applications27 Nov 2025US 2025/0361278 A1Phycin Inc.
- Cancer-killing cells23 Oct 2025US 2025/0325584 A1LIfT BioSciences Ltd
Most cited
By later US patents